Veracyte has appointed a Market Access & Reimbursement Advisor to shape its private payor strategy across the United States. The role is central to securing broader reimbursement for Veracyte’s diagnostic portfolio, ensuring favourable rates and meaningful patient access at scale.
By building a targeted strategy for national private payor engagement, the appointment enhances Veracyte’s ability to expand coverage, reduce barriers to adoption, and accelerate the clinical impact of its advanced genomic tests across key therapeutic areas.
